These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 308527)

  • 1. Effects of amiodarone studied by programmed electrical stimulation of the heart in patients with paroxysmal re-entrant supraventricular tachycardia.
    Waleffe A; Bruninx P; Kulbertus HE
    J Electrocardiol; 1978 Jul; 11(3):253-60. PubMed ID: 308527
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of amiodarone in the Wolff-Parkinson-White syndrome.
    Wellens HJ; Lie KI; Bär FW; Wesdorp JC; Dohmen HJ; Düren DR; Durrer D
    Am J Cardiol; 1976 Aug; 38(2):189-94. PubMed ID: 952262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous amiodarone in the acute termination of supraventricular arrhythmias.
    Holt P; Crick JC; Davies DW; Curry P
    Int J Cardiol; 1985 May; 8(1):67-79. PubMed ID: 3997293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Control of tachyarrhythmias associated with Wolff-Parkinson-White syndrome by amiodarone hydrochloride.
    Rosenbaum MB; Chiale PA; Ryba D; Elizari MV
    Am J Cardiol; 1974 Aug; 34(2):215-23. PubMed ID: 4843156
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of amiodarone in paroxysmal supraventricular tachycardia with or without Wolff-Parkinson-White syndrome.
    Wellens HJ; Brugada P; Abdollah H
    Am Heart J; 1983 Oct; 106(4 Pt 2):876-80. PubMed ID: 6613833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of amiodarone in the Wolff-Parkinson-White syndrome. A clinical and electrophysiological study.
    Rasmussen V; Berning J
    Acta Med Scand; 1979; 205(1-2):31-7. PubMed ID: 367085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrophysiological assessment of amiodarone in treatment of resistant supraventricular arrhythmias.
    Rowland E; Krikler DM
    Br Heart J; 1980 Jul; 44(1):82-90. PubMed ID: 7426165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conversion of atrial fibrillation to sinus rhythm with amiodarone.
    Santos AL; Aleixo AM; Landeiro J; Luís AS
    Acta Med Port; 1979; 1(1):15-23. PubMed ID: 549456
    [No Abstract]   [Full Text] [Related]  

  • 9. Electrophysiologic effects of amiodarone in tachyarrhythmias.
    Liu PH; Lin CC; Ko GC; Wang DJ; Shieh SM; Sung PK
    Taiwan Yi Xue Hui Za Zhi; 1985 Jul; 84(7):759-75. PubMed ID: 3864917
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of amiodarone in the Wolff-Parkinson-White syndrome with rapid ventricular response via accessory pathway during atrial fibrillation.
    Kappenberger LJ; Fromer MA; Steinbrunn W; Shenasa M
    Am J Cardiol; 1984 Aug; 54(3):330-5. PubMed ID: 6465013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of termination of re-entrant paroxysmal supraventricular tachycardia in WPW syndrome by IV amiodarone.
    Khalilullah M; Gambhir DS; Bahl VK; Ahmed M; Balachander J; Gupta R
    Indian Heart J; 1985; 37(1):18-22. PubMed ID: 4007912
    [No Abstract]   [Full Text] [Related]  

  • 12. [Sotalol in supraventricular tachycardia. Electrophysiologic measurements in Wolff-Parkinson-White syndrome and AV node re-entry tachycardia].
    Manz M; Kuhl AJ; Lüderitz B
    Z Kardiol; 1985 Sep; 74(9):500-5. PubMed ID: 4060827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of intravenous diltiazem administration in patients with inducible tachycardia.
    Waleffe A; Hastir F; Kulbertus HE
    Eur Heart J; 1985 Oct; 6(10):882-90. PubMed ID: 4076199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophysiologic basis for the suppression by amiodarone of orthodromic supraventricular tachycardias complicating pre-excitation syndromes.
    Feld GK; Nademanee K; Weiss J; Stevenson W; Singh BN
    J Am Coll Cardiol; 1984 May; 3(5):1298-307. PubMed ID: 6707383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical antiarrhythmic effects of amiodarone in patients with resistant paroxysmal tachycardias.
    Ward DE; Camm AJ; Spurrell RA
    Br Heart J; 1980 Jul; 44(1):91-5. PubMed ID: 7426166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repetitive supraventricular tachycardia: clinical manifestations and response to therapy with amiodarone.
    Haines DE; Lerman BB; DiMarco JP
    Pacing Clin Electrophysiol; 1986 Jan; 9(1 Pt 1):130-3. PubMed ID: 2419843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Electrophysiologic studies on tachycardia with dual A-V nodal pathway reentry and the effects of amiodarone].
    Wu N; Jin L; Yu GM
    Zhonghua Xin Xue Guan Bing Za Zhi; 1985 Mar; 13(1):10-3, 76-7. PubMed ID: 4006696
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of disopyramide on electrophysiological properties of specialized conduction system in man and on accessory atrioventricular pathway in Wolff-Parkinson-White syndrome.
    Spurrell RA; Thorburn CW; Camm J; Sowton E; Deuchar DC
    Br Heart J; 1975 Aug; 37(8):861-7. PubMed ID: 53057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Action and adverse effects of amiodarone in Wolff-Parkinson-White syndrome].
    Cosma C; Crepin D; Py J
    Nouv Presse Med; 1979 Mar; 8(11):865. PubMed ID: 450659
    [No Abstract]   [Full Text] [Related]  

  • 20. Amiodarone for refractory automatic atrial tachycardia: observations on the electrophysiological actions of amiodarone.
    Wiener I; Lyons H
    Pacing Clin Electrophysiol; 1984 Jul; 7(4):707-9. PubMed ID: 6205373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.